Home › Overweight › California › Los Angeles
Pag-aaral pangklinika para sa Overweight sa Los Angeles, CA
Isang pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Los Angeles. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Nagre-recruitPhase 2
- Los Angeles Institute for Metabolic Research /ID# 282059, Los Angeles
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Nagre-recruit
- Cedars Sinai Medical Center, Los Angeles
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Nagre-recruitPhase 3
- Los Angeles Institute for Metabolic Research, Los Angeles
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Nagre-recruitPhase 3
- Childrens Hospital of Los Angeles, Los Angeles
- UCLA Mattel Children's Hospital, Los Angeles
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Nagre-recruitPhase 3
- Inglewood Clinical, Los Angeles
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Nagre-recruitPhase 3
- AURORA-2 Clinical Site, Los Angeles
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Nagre-recruitPhase 3
- AURORA-1 Clinical Site, Los Angeles
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Nagre-recruitPhase 3
- Los Angeles Institute for Metabolic Research, Los Angeles
Effects of Dietary Supplements on Muscle Mass and Function While Using GLP-1 Medication
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- UCLA Center for Human Nutrition, Los Angeles
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Nagre-recruitPhase 4
- Metropolis Dermatology, Los Angeles
Avoid and Resist Strategies for Weight Management
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Cedars-Sinai Medical Center, Los Angeles
BrainWeighve App Feasibility Study
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- UCLA Marion Davies Children's Center, Los Angeles
eMOTION: Examining Implicit Attitudes in Physical Activity Engagement
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Univeristy of Southern California, Los Angeles
Tirzepatide for Alcohol Use Disorder
Nagre-recruitPhase 2
- Keck School of Medicine, University of Southern California, Los Angeles
eMOTION: Examining Affective Mechanisms in Physical Activity Engagement
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- University of Southern California, Los Angeles
Pag-aaral para sa Overweight sa ibang lungsod
- San Antonio, TX34 pag-aaral
- Houston, TX33 pag-aaral
- Chicago, IL29 pag-aaral
- Orlando, FL27 pag-aaral
- Las Vegas, NV23 pag-aaral
- Miami, FL23 pag-aaral
- Dallas, TX20 pag-aaral
- Atlanta, GA20 pag-aaral
- New York City, NY19 pag-aaral
- Jacksonville, FL19 pag-aaral
- Washington, DC19 pag-aaral
- Austin, TX18 pag-aaral
Iba pang pag-aaral sa Los Angeles
- Non-Small Cell Lung Cancer87 pag-aaral
- Kanser (lahat ng uri)74 pag-aaral
- Kanser sa Suso73 pag-aaral
- Kanser sa Prostate61 pag-aaral
- Colorectal Cancer59 pag-aaral
- Metastatic Cancer57 pag-aaral
- Kanser sa Ovary50 pag-aaral
- Kanser sa Baga45 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg42 pag-aaral
- Kanser sa Pancreas35 pag-aaral
- Kanser ng Endometrium34 pag-aaral
- Melanoma34 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.